BACKGROUND: Injecting drug users (IDUs) are at increased risk of acquiring and transmitting HIV and other bloodborne pathogens through the multi-person use of syringes. Although research has shown that increased access to syringes through syringe exchange programs (SEPs) is an effective strategy to reduce risky injection practices many areas of the United States still do not have SEPs. In the absence of SEPs, legislation allowing pharmacies over-the-counter sales of syringes has also been shown to reduce syringe sharing. The success of pharmacy sales however is limited by other legal stipulations, such as drug paraphernalia laws, which in turn may contribute to fear among IDUs about being caught purchasing and carrying syringes. METHODS: Between 2003 and 2006, 851 out-of-treatment IDUs were recruited using street outreach in the Raleigh-Durham (North Carolina) area. Data were collected using audio-computer assisted interview (ACASI) technology. Multiple logistic regression analyses were performed to assess factors associated with purchasing syringes from pharmacies. RESULTS: In our study sample, African-American IDUs were one-fifth as likely as white IDUs to report pharmacies as their primary source of syringes. CONCLUSIONS: Given the absence of syringe exchange programs and the relatively high prevalence of HCV and HIV among IDUs in the Raleigh-Durham area, the limited use of pharmacies as a source of syringes among African-American IDUs in this study sample is problematic. The study findings support the need for effective multilevel interventions to increase access to clean needles in this population, as well as for policy interventions, such as legalization of SEPs and elimination of penalties for carrying syringes, to reduce harm and eliminate the health threats posed by receptive syringe sharing. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND: Injecting drug users (IDUs) are at increased risk of acquiring and transmitting HIV and other bloodborne pathogens through the multi-person use of syringes. Although research has shown that increased access to syringes through syringe exchange programs (SEPs) is an effective strategy to reduce risky injection practices many areas of the United States still do not have SEPs. In the absence of SEPs, legislation allowing pharmacies over-the-counter sales of syringes has also been shown to reduce syringe sharing. The success of pharmacy sales however is limited by other legal stipulations, such as drug paraphernalia laws, which in turn may contribute to fear among IDUs about being caught purchasing and carrying syringes. METHODS: Between 2003 and 2006, 851 out-of-treatment IDUs were recruited using street outreach in the Raleigh-Durham (North Carolina) area. Data were collected using audio-computer assisted interview (ACASI) technology. Multiple logistic regression analyses were performed to assess factors associated with purchasing syringes from pharmacies. RESULTS: In our study sample, African-American IDUs were one-fifth as likely as white IDUs to report pharmacies as their primary source of syringes. CONCLUSIONS: Given the absence of syringe exchange programs and the relatively high prevalence of HCV and HIV among IDUs in the Raleigh-Durham area, the limited use of pharmacies as a source of syringes among African-American IDUs in this study sample is problematic. The study findings support the need for effective multilevel interventions to increase access to clean needles in this population, as well as for policy interventions, such as legalization of SEPs and elimination of penalties for carrying syringes, to reduce harm and eliminate the health threats posed by receptive syringe sharing. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Samuel R Friedman; Hannah Lf Cooper; Barbara Tempalski; Maria Keem; Risa Friedman; Peter L Flom; Don C Des Jarlais Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Wendy Reich; Wilson M Compton; Joe C Horton; Linda B Cottler; Renee M Cunningham-Williams; Robert Booth; Merrill Singer; Carl Leukefeld; Joseph Fink; Tom Stopka; Karen Fortuin Corsi; Michelle Staton Tindall Journal: J Am Pharm Assoc (Wash) Date: 2002 Nov-Dec
Authors: Theresa E Perlis; Don C Des Jarlais; Samuel R Friedman; Kamyar Arasteh; Charles F Turner Journal: Addiction Date: 2004-07 Impact factor: 6.526
Authors: Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral Journal: Am J Epidemiol Date: 2012-05-04 Impact factor: 4.897
Authors: Tanner Nassau; Alia Al-Tayyib; William T Robinson; Jennifer Shinefeld; Kathleen A Brady Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Saira S Siddiqui; Richard F Armenta; Jennifer L Evans; Michelle Yu; Jazmine Cuevas-Mota; Kimberly Page; Peter Davidson; Richard S Garfein Journal: Int J Drug Policy Date: 2015-06-24
Authors: William A Zule; Christine Oramasionwu; Donna Evon; Sayaka Hino; Irene A Doherty; Georgiy V Bobashev; Wendee M Wechsberg Journal: Am J Drug Alcohol Abuse Date: 2016-06-10 Impact factor: 3.829
Authors: Corey S Davis; Jill Johnston; Lisa de Saxe Zerden; Katie Clark; Tessie Castillo; Robert Childs Journal: Drug Alcohol Depend Date: 2014-08-25 Impact factor: 4.492